KORU Medical Highlights Efficiency Gains in Subcutaneous Infusion Study
Event summary
- KORU Medical presented real-world data at the 51st Annual Oncology Nursing Society Congress on May 13-17, 2026.
- Study across four U.S. infusion centers showed 100% successful dose administration with FreedomEDGE system.
- Nurses reported 80% ability to multitask during infusions, with high satisfaction scores from both nurses (4.85/5) and patients (4.92/5).
- Freedom System supports 9 on-label subcutaneous drugs with 97% adherence rate across 59,000+ patients annually.
The big picture
The study results position KORU Medical's FreedomEDGE system as a potential workflow differentiator in the growing subcutaneous infusion market. With oncology nursing staff shortages persisting, solutions that reduce ergonomic strain and improve multitasking capabilities could gain significant traction. The company's 15-year track record in home self-administration gives it an established base to build upon in the ambulatory care setting.
What we're watching
- Adoption Pace
- Whether the positive real-world results will accelerate FreedomEDGE adoption in community infusion centers.
- Competitive Response
- How competitors in subcutaneous infusion technology may react to these efficiency metrics.
- Regulatory Expansion
- The pace at which KORU Medical can expand its 30+ country approval footprint with this clinical validation.
Related topics